MSD Korea Ltd. is a Korea corporation of Merck & Co,. Inc as a global health care company. It was established in 1994. We provide great ETC & OTC products & information in Korea.
We make difference in the lives of people globally through our innovative medicines, vaccines, consumer health products
Booth No. B06
Lunchtime Activities | |
Benefit of Adding Ezetimibe to Statin Therapy in Coronary Patients | |
Organized by CVRF and Supported by Educational Grant from MSD Korea | |
Tuesday, May 01 12:45 PM - 1:45 PM Room 105, Level 1 |
|
Moderator(s): Hun Sik Park | |
Panelist(s): Jong-Young Lee | |
12:45 PM | Opening Remark
Speaker : Hun Sik Park
|
12:50 PM | Benefit of Adding Ezetimibe to Statin Therapy in Coronary Patients
Lecturer : Jong-Young Lee
|
1:30 PM | Q&A and Discussion |